What is the recommended dosage of ranitidine?

Ranitidine Dosing Recommendations

For anaphylaxis treatment, administer ranitidine 50 mg IV in adults and 1 mg/kg (12.5-50 mg) IV in children, diluted in 5% dextrose to 20 mL total volume and injected over 5 minutes. 1

Clinical Context-Specific Dosing

Anaphylaxis (Emergency Setting)

• Adults: 50 mg IV over 5 minutes
• Pediatrics: 1 mg/kg IV (range 12.5-50 mg) over 5 minutes
• Preparation: Dilute in 5% dextrose to total volume of 20 mL
• Critical caveat: Ranitidine is second-line therapy only to epinephrine and should never be used alone. The combination of diphenhydramine plus ranitidine is superior to diphenhydramine alone, but both have much slower onset than epinephrine 1

Gastrointestinal Indications (Oral Dosing)

Adults 2:

• Active duodenal/gastric ulcer: 150 mg twice daily OR 300 mg once daily at bedtime
• Ulcer maintenance: 150 mg at bedtime
• GERD: 150 mg twice daily
• Erosive esophagitis (acute): 150 mg four times daily
• Erosive esophagitis (maintenance): 150 mg twice daily
• Zollinger-Ellison syndrome: 150 mg twice daily initially; may require more frequent dosing up to 6 g/day in severe disease

Pediatrics (ages 1 month to 16 years) 3, 2:

• Duodenal/gastric ulcer treatment: 2-4 mg/kg twice daily (maximum 300 mg/day)
• Ulcer maintenance: 2-4 mg/kg once daily (maximum 150 mg/day)
• GERD/erosive esophagitis: 5-10 mg/kg/day divided in 2 doses 3

Special Populations

Renal Impairment 2:

• Creatinine clearance <50 mL/min: 150 mg every 24 hours
• May increase frequency to every 12 hours with caution if clinically required
• Time dosing to coincide with end of hemodialysis when applicable

Elderly Patients 2:

• Exercise caution in dose selection due to age-related decline in renal function
• Monitor renal function and adjust accordingly
• Consider starting at lower end of dosing range

Pregnancy 4:

• For refractory heartburn: 150 mg twice daily (shown to be more effective than once-daily dosing)
• Use only if potential benefit justifies potential fetal risk

Important Clinical Pitfalls

1. Neonates (<1 month): Insufficient pharmacokinetic data exists to make dosing recommendations 2

2. Frequency matters: For erosive esophagitis, 150 mg four times daily is significantly more effective than 300 mg twice daily (77% vs 66% healing at 12 weeks) 5

3. Critically ill children requiring stress ulcer prophylaxis: 1.5 mg/kg IV every 6 hours maintains gastric pH ≥4 in 80% of patients 6

4. Drug withdrawal context: Ranitidine was withdrawn from markets worldwide in 2020 due to NDMA contamination concerns, though subsequent research showed no increased cancer risk compared to other H2-receptor antagonists 7